Israel Active

Israel’s Sheba Medical Center has signed a strategic agreement with Abu Dhabi-based innovation giant G42 Healthcare to develop new health technology. Plans include joint projects in stem cell research, cardiology, oncology, obstetrics, gynecology, diabetes, fertility, and more.

Yeshiva University (YU), together with Amudim Israel, have opened the Jerusalem Therapy Center. It fulfills a critical need for affordable, English-language mental health services, serving those impacted by trauma, addiction, and other complex mental health related issues.

Israel’s X-trodes (see previously) has partnered US-based EMOTIV to launch a first-of-its-kind medical-grade wearable solution for brain and physiological monitoring outside of clinical settings. X-trodes’ multi-electrode skin patches measure a patient’s EEG, EMG and ECG signals.

Israel’s TytoCare (see previously) has launched its Home Smart Clinic. It conducts remote physical exams using AI-powered guidance and diagnostic support. The virtual clinic includes the remote handheld diagnostic device plus Tyto Insights, Tyto Engagement Labs, plus all necessary support.

Israel’s Radiaction Medical has received US FDA clearance for its Radiation Shielding System. The system protects medical staff in labs using fluoroscopy machines - a leading source of occupational ionizing radiation exposure for healthcare providers.

The HearO app from Israel’s Cordio Medical (see previously) achieved an 82% success rate in a study of 180 patients at 10 Israeli clinics. The app detected Congestive Heart Failure (CHF) an average of 18 days before it occurred, using algorithms and previously recorded speech.

Hundreds of Israeli hi-tech employees volunteer in the Code for Israel initiative to benefit Israeli society. One group founded the Pathomatic Project and developed an algorithm that immediately alerts medical staff, at Tel Aviv’s Ichilov (Sourasky) hospital, to cancer biopsy scans.

Tel Aviv University researchers have used a combination of low-frequency ultrasound and injected nanobubbles to cause tumors to explode. Lab tests focused only on the area of the tumor, which avoids damage to healthy tissues. It could be used to treat tumors deep inside the body.

Tel Aviv University researchers have found that regular aerobic exercise reduces the risk of metastatic cancer by up to 72%. In data studies of 3,000 humans, plus lab tests, they have shown that exercise increases glucose consumption, thereby reducing the availability of energy to the tumor.

Researchers at Tel Aviv University are developing a water-based gel (hydrogel) that will encourage bones to re-grow. It has extensive dental and orthopedic applications (e.g., for implants and repairing bone defects). Following lab tests, clinical (human) trials are now planned.